🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to compare the rate and extent of absorption...
Status
Completed
Location
Anapharm Inc.
Start Date
2002-01
Trial ID
NCT00835263
Treatments Being Tested
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
The main goal is to reveal differences in global gene expression in two dif...
Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Start Date
2020-01-31
Trial ID
NCT04034706
This is a single site blinded RCT of 920 pregnant women with singleton gest...
Status
Completed
Location
UPMC- Magee Womens Hospital
Start Date
2015-08-11
Trial ID
NCT02309138
Muscle atrophy may occur in individuals with spinal cord injury (SCI) as a ...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-21
Trial ID
NCT03859960
Treatments Being Tested
a study to investigate the pharmacokinetic characteristics and safety/toler...
Status
Unknown
Location
Gachon University Gil Medical Center
Start Date
2019-04-01
Trial ID
NCT03920579
Treatments Being Tested
This study involves 2 parts, Part A and Part B. The purpose of Part A is to...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2012-09
Trial ID
NCT01681186
Treatments Being Tested
The continual glucose is going to increase time-in-range compared to the st...
Status
Completed
Location
OHSU
Start Date
2021-02-11
Trial ID
NCT04605497
Treatments Being Tested
The pharmacokinetics behavior of the test formulation T1 and the control fo...
Status
Completed
Location
Wuhan Central Hospital
Start Date
2024-09-15
Trial ID
NCT06610903
Treatments Being Tested
In order to assess the potential impact of steady state BI 425809 on CYP3A ...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2022-03-18
Trial ID
NCT05258110
Treatments Being Tested